Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACMSD | Q8TDX5 | 3/20 | 0.88 |
| ▸ | HNF4A | P41235 | 2/20 | 0.88 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.64 |
| ▸ | CA12 | O43570 | 1/20 | 0.64 |
| ▸ | CA1 | P00915 | 1/20 | 0.64 |
| ▸ | CA2 | P00918 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | CA7 | P43166 | 1/20 | 0.64 |
| ▸ | CA9 | Q16790 | 1/20 | 0.64 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.64 |
| ▸ | PPM1B | O75688 | 1/20 | 0.63 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.61 |
| ▸ | DHFR | P00374 | 1/20 | 0.61 |
| ▸ | XDH | P47989 | 3/20 | 0.61 |
| ▸ | SLC22A12 | Q96S37 | 3/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2773864 | 0.98 | ACMSD (0.83) | ACMSDHNF4AALDH1A1CA12CA1 | |
| SCHEMBL29441950 | 0.98 | ACMSD (0.83) | ACMSDHNF4AALDH1A1CA12CA1 | |
| SCHEMBL22126663 | 0.94 | ACMSD (0.78) | ACMSDHNF4AALDH1A1CA12CA1 | |
| SCHEMBL29810721 | 0.94 | ACMSD (1.00) | ACMSDHNF4AALDH1A1CA12CA1 | |
| SCHEMBL2536183 | 0.94 | ACMSD (1.00) | ACMSDHNF4AALDH1A1CA12CA1 | |
| SCHEMBL30456738 | 0.93 | ACMSD (0.77) | ACMSDHNF4AALDH1A1CA12CA1 | |
| SCHEMBL31070130 | 0.92 | ACMSD (0.75) | ACMSDHNF4AALDH1A1CA12CA1 | |
| SCHEMBL28364476 | 0.92 | ACMSD (0.75) | ACMSDHNF4AALDH1A1CA12CA1 | |
| SCHEMBL17618931 | 0.90 | ACMSD (0.72) | ACMSDHNF4AALDH1A1CA12CA1 | |
| SCHEMBL6490071 | 0.90 | ACMSD (0.72) | ACMSDHNF4AALDH1A1CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240199478-A1 | High Optical Transmission Amphiphobic Surfaces; and Methods of Forming Them | UCL BUSINESS LTD (GB) | 2024-06-20 | — | — | US | claimed |
| EP-4301711-A1 | HIGH OPTICAL TRANSMISSION AMPHIPHOBIC SURFACES; AND METHODS OF FORMING THEM | UCL Business Ltd (GB) | 2024-01-10 | — | — | EP | claimed |
| WO-2022184793-A1 | HIGH OPTICAL TRANSMISSION AMPHIPHOBIC SURFACES; AND METHODS OF FORMING THEM | UCL BUSINESS LTD (GB) | 2022-09-09 | — | — | WO | claimed |
| US-20240424488-A1 | High-Entropy Metal-Organic Frameworks | NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA, LLC | 2024-12-26 | — | — | US | disclosed |
| US-20240199478-A1 | High Optical Transmission Amphiphobic Surfaces; and Methods of Forming Them | UCL BUSINESS LTD (GB) | 2024-06-20 | — | — | US | disclosed |
| EP-4301711-A1 | HIGH OPTICAL TRANSMISSION AMPHIPHOBIC SURFACES; AND METHODS OF FORMING THEM | UCL Business Ltd (GB) | 2024-01-10 | — | — | EP | disclosed |
| WO-2022184793-A1 | HIGH OPTICAL TRANSMISSION AMPHIPHOBIC SURFACES; AND METHODS OF FORMING THEM | UCL BUSINESS LTD (GB) | 2022-09-09 | — | — | WO | disclosed |
| US-20170101429-A1 | METAL ORGANIC FRAMEWORKS COMPRISING A PLURALITY OF SBUS WITH DIFFERENT METAL IONS AND/OR A PLURALITY OF ORGANIC LINKING LIGANDS WITH DIFFERENT FUNCTIONAL GROUPS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2017-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170101429-A1 | METAL ORGANIC FRAMEWORKS COMPRISING A PLURALITY OF SBUS WITH DIFFERENT METAL IONS AND/OR A PLURALITY OF ORGANIC LINKING LIGANDS WITH DIFFERENT FUNCTIONAL GROUPS | EPCAM, SOD1, SBDS | ACMSD 3537/4885HNF4A 2293/4885ALDH1A1 1971/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.